Cheng‐Po Hu

806 total citations
27 papers, 699 citations indexed

About

Cheng‐Po Hu is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Cheng‐Po Hu has authored 27 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Cheng‐Po Hu's work include Hepatitis B Virus Studies (9 papers), Immunotherapy and Immune Responses (5 papers) and Hepatitis C virus research (5 papers). Cheng‐Po Hu is often cited by papers focused on Hepatitis B Virus Studies (9 papers), Immunotherapy and Immune Responses (5 papers) and Hepatitis C virus research (5 papers). Cheng‐Po Hu collaborates with scholars based in Taiwan, China and United States. Cheng‐Po Hu's co-authors include Chung-Ming Chang, Chungming Chang, Wing‐Yiu Lui, Szecheng J. Lo, Chen‐Kung Chou, Jen‐Hwey Chiu, Ah‐Kau Ng, Sue‐Jane Lin, Fang‐Ku P’eng and Shou‐Hwa Han and has published in prestigious journals such as Nucleic Acids Research, The Journal of Immunology and Molecular and Cellular Biology.

In The Last Decade

Cheng‐Po Hu

27 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng‐Po Hu Taiwan 16 283 217 182 148 136 27 699
Eugene Dempsey Ireland 15 318 1.1× 140 0.6× 79 0.4× 111 0.8× 163 1.2× 24 686
Andrea L. George United States 12 382 1.3× 107 0.5× 172 0.9× 56 0.4× 230 1.7× 27 766
Ahmed Lasfar United States 19 324 1.1× 165 0.8× 368 2.0× 131 0.9× 433 3.2× 30 981
Anthony J. Scarzello United States 14 264 0.9× 184 0.8× 296 1.6× 125 0.8× 456 3.4× 16 886
Rom T. Altstock Israel 8 220 0.8× 247 1.1× 54 0.3× 80 0.5× 165 1.2× 11 669
C A Parkos United States 7 319 1.1× 61 0.3× 83 0.5× 109 0.7× 405 3.0× 8 949
Satoru Tsuruta Japan 17 140 0.5× 75 0.3× 94 0.5× 45 0.3× 138 1.0× 56 638
José Luis Vela United States 18 312 1.1× 137 0.6× 100 0.5× 53 0.4× 611 4.5× 27 955
Nianli Liu China 16 401 1.4× 108 0.5× 117 0.6× 123 0.8× 181 1.3× 33 714
Arnaud Dupuy d’Angeac France 11 251 0.9× 85 0.4× 169 0.9× 29 0.2× 410 3.0× 28 886

Countries citing papers authored by Cheng‐Po Hu

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Po Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Po Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Po Hu more than expected).

Fields of papers citing papers by Cheng‐Po Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Po Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Po Hu. The network helps show where Cheng‐Po Hu may publish in the future.

Co-authorship network of co-authors of Cheng‐Po Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Po Hu. A scholar is included among the top collaborators of Cheng‐Po Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Po Hu. Cheng‐Po Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsai, Shu‐Huai, Yiwen Liu, Weichun Tang, et al.. (2007). Characterization of porcine arterial endothelial cells cultured on amniotic membrane, a potential matrix for vascular tissue engineering. Biochemical and Biophysical Research Communications. 357(4). 984–990. 35 indexed citations
2.
Lin, Sue‐Jane, et al.. (2007). Prevention of TGF-β-induced apoptosis by interlukin-4 through Akt activation and p70S6K survival signaling pathways. APOPTOSIS. 12(9). 1659–1670. 16 indexed citations
3.
Lin, Sue‐Jane, Pei‐Yun Shu, Chung-Ming Chang, Ah‐Kau Ng, & Cheng‐Po Hu. (2003). IL-4 Suppresses the Expression and the Replication of Hepatitis B Virus in the Hepatocellular Carcinoma Cell Line Hep3B. The Journal of Immunology. 171(9). 4708–4716. 58 indexed citations
5.
Dou, Horng-Yunn, et al.. (1998). Analysis of T cell receptor Vβ gene usage during the course of disease in patients with chronic hepatitis B. Journal of Biomedical Science. 5(6). 428–434. 7 indexed citations
6.
Tsou, Ann‐Ping, Keh-Ming Wu, Chin‐Wen Chi, et al.. (1998). Parallel Hybridization Analysis of Multiple Protein Kinase Genes: Identification of Gene Expression Patterns Characteristic of Human Hepatocellular Carcinoma. Genomics. 50(3). 331–340. 68 indexed citations
7.
Wang, Shengyuan, et al.. (1993). Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads.. PubMed. 13(6A). 2281–5. 5 indexed citations
8.
Chiu, Jen‐Hwey, Cheng‐Po Hu, Wing‐Yiu Lui, Szecheng J. Lo, & Chungming Chang. (1990). The Formation of Bile Canaliculi in Human Hepatoma Cell Lines. Hepatology. 11(5). 834–842. 58 indexed citations
9.
Tsai, Ting‐Fen, Yar‐Khing Yauk, Chen-Kung Chou, et al.. (1988). Evidence of autocrine regulation in human hepatoma cell lines. Biochemical and Biophysical Research Communications. 153(1). 39–45. 43 indexed citations
10.
Chen, Yi‐Ming, et al.. (1988). Nuclear antigens reacted with sera and ascites of hepatocellular carcinoma patients. Hepatology. 8(3). 547–552. 5 indexed citations
11.
Chien, Shu‐Chen, Cheng‐Po Hu, Shou‐Dong Lee, et al.. (1988). Natural and activated cytotoxic lymphocytes reactivity to human hepatocellular carcinoma cell lines in hepatocellular carcinoma patients. Liver International. 8(4). 198–207. 6 indexed citations
12.
Chen, Jen‐Yang, Chien‐Jen Chen, Mei‐Ying Liu, et al.. (1987). Antibodies to Epstein‐Barr virus‐specific DNase in patients with nasopharyngeal carcinoma and control groups. Journal of Medical Virology. 23(1). 11–21. 34 indexed citations
13.
Chao, Kuan‐Chong, Heung‐Tat Ng, Chi‐Ching Chang, Cheng‐Po Hu, & Chungming Chang. (1987). Properties of Ectopic Proteins Synthesis in vitro by Human Cervical Carcinoma Cells. Asia-Oceania Journal of Obstetrics and Gynaecology. 13(2). 221–226. 1 indexed citations
14.
Wuu, Kuang-Dong, et al.. (1987). Karyotypic characterization of an established human hepatoma cell line HA22T/VGH. Cancer Genetics and Cytogenetics. 26(2). 279–286. 5 indexed citations
15.
Masucci, Maria G., Robert Szigeti, Ingemar Ernberg, et al.. (1987). Activation of B lymphocytes by Epstein‐Barr virus/CR2 receptor interaction. European Journal of Immunology. 17(6). 815–820. 26 indexed citations
16.
Hu, Cheng‐Po, Pierre Åman, Maria G. Masucci, Eva Klein, & George Klein. (1986). B cell activation by the nontransforming P3HR‐1 substrain of the Epstein‐Barr virus (EBV). European Journal of Immunology. 16(7). 841–845. 15 indexed citations
17.
Su, Tsung‐Sheng, Chen‐Kung Chou, Chungming Chang, et al.. (1986). Hepatitis B virus transcripts in a human hepatoma cell line, hep 3B. Biochemical and Biophysical Research Communications. 138(1). 131–138. 12 indexed citations
18.
Hu, Cheng‐Po, et al.. (1985). Cellular and antigenic properties of cultured normal and fetal brain and glioma cells. Journal of Neuroimmunology. 8(2-3). 141–151. 6 indexed citations
19.
Su, Tsung‐Sheng, Wing‐Yiu Lui, Chungming Chang, et al.. (1985). Expression of c-myc gene in human hepatoma. Biochemical and Biophysical Research Communications. 132(1). 264–268. 29 indexed citations
20.
Hu, Cheng‐Po, Kun‐Yi Chien, Pei‐Yu Wang, et al.. (1984). Biologic Properties of Three Newly Established Human Esophageal Carcinoma Cell Lines<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 72(3). 577–83. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026